M, R., JM, M., A, M., JA, A. G., M, M. B., A, F. C., . . . Network, S. (2022). The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.
Citación estilo ChicagoM, Rubio-Rivas, et al. The Use of Corticosteroids or Tocilizumab in COVID-19 Based On Inflammatory Markers. 2022.
Cita MLAM, Rubio-Rivas, et al. The Use of Corticosteroids or Tocilizumab in COVID-19 Based On Inflammatory Markers. 2022.
Precaución: Estas citas no son 100% exactas.